On this page you will find proposed changes that are currently going through the GMMMG approval process. This will include consultations on proposed RAG status, updated formulary chapters, pathways or other GMMMG guidance. You can comment on current proposals via the links in the table below.

GMMMG are mindful of additional service pressures at present, therefore consultations opened in December 2021 will run for eight weeks instead of the usual six. Consultations scheduled to close in December have been extended. All closing dates will be kept under review to ensure all stakeholders have opportunity to participate.

Every effort has been made to allow sufficient time for appropriate clinical input to these documents, but if you foresee any problems or have any questions please contact the secretariat at nuth.enquires.gmmmg@nhs.net.

Title Information Feedback End Date
GMMMG HRT for menopause guidance On behalf of GMMMG, we now seek comments on this draft version of new HRT for menopause guidance. This consultation period is open until 5pm on Thursday 17th February 2022.
NB: this consultation includes five documents in a zipped folder.
Feedback Form February 17th, 2022
GMMMG primary care rebate scheme ethical framework On behalf of GMMMG, we now seek comments on this draft version of the updated GM ethical framework for primary care rebate schemes. This consultation period is open until 5pm on Monday 14th February 2022.
NB: this consultation includes three documents in a zipped folder.
Feedback Form February 14th, 2022
GMMMG Neuropathic Pain pathway On behalf of the GMMMG neuropathic pain working group, we now seek comments on this draft version of the updated GM neuropathic pain pathway. This consultation period is open until 5pm on Monday 14th February 2022.
NB: this consultation includes two documents in a zipped folder.
Feedback Form February 14th, 2022
GMMMG Headache pathway On behalf of the GMMMG headache working group, we now seek comments on this draft version of the updated GM headache pathway. This consultation period is open until 5pm on Monday 14th February 2022.
NB: this consultation includes three documents in a zipped folder.
Feedback Form February 14th, 2022
High Cost Drugs Pathway - Rheumatoid Arthritis On behalf of the GMMMG RA working group, we now seek comments on this draft version of the updated GM high cost drug rheumatoid arthritis pathway. This consultation period is open until 5pm on Monday 14th February 2022. Feedback Form February 14th, 2022
GMMMG Clinical Reference Group proposed actions from December 2021 On behalf of the GMMMG Clinical Reference Group, we now seek comments on the actions proposed at the October 2021 CRG meeting. This consultation period is open until 5pm on Monday 14th February 2022 Feedback Form February 14th, 2022